Adherence to Opioid Patient Prescriber Agreements at a Safety Net Hospital
- PMID: 37296905
- PMCID: PMC10251943
- DOI: 10.3390/cancers15112943
Adherence to Opioid Patient Prescriber Agreements at a Safety Net Hospital
Abstract
Patient prescriber agreements, also known as opioid contracts or opioid treatment agreements, have been recommended as a strategy for mitigating non-medical opioid use (NMOU). The purpose of our study was to characterize the proportion of patients with PPAs, the rate of non-adherence, and clinical predictors for PPA completion and non-adherence. This retrospective study covered consecutive cancer patients seen at a palliative care clinic at a safety net hospital between 1 September 2015 and 31 December 2019. We included patients 18 years or older with cancer diagnoses who received opioids. We collected patient characteristics at consultation and information regarding PPA. The primary purpose was to determine the frequency and predictors of patients with a PPA and non-adherence to PPAs. Descriptive statistics and multivariable logistic regression models were used for the analysis. The survey covered 905 patients having a mean age of 55 (range 18-93), of whom 474 (52%) were female, 423 (47%) were Hispanic, 603 (67%) were single, and 814 (90%) had advanced cancer. Of patients surveyed, 484 (54%) had a PPA, and 50 (10%) of these did not adhere to their PPA. In multivariable analysis, PPAs were associated with younger age (odds ratio [OR] 1.44; p = 0.02) and alcohol use (OR 1.72; p = 0.01). Non-adherence was associated with males (OR 3.66; p = 0.007), being single (OR 12.23; p = 0.003), tobacco (OR 3.34; p = 0.03) and alcohol use (OR 0.29; p = 0.02), contact with persons involved in criminal activity (OR 9.87; p < 0.001), use for non-malignant pain (OR 7.45; p = 0.006), and higher pain score (OR 1.2; p = 0.01). In summary, we found that PPA non-adherence occurred in a substantial minority of patients and was more likely in patients with known NMOU risk factors. These findings underscore the potential role of universal PPAs and systematic screening of NMOU risk factors to streamline care.
Keywords: analgesics; cancer pain; contract; illicit drugs; neoplasm; opioid; opioid-related disorders; pain management; palliative care.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Frequency of and Factors Associated With Nonmedical Opioid Use Behavior Among Patients With Cancer Receiving Opioids for Cancer Pain.JAMA Oncol. 2021 Mar 1;7(3):404-411. doi: 10.1001/jamaoncol.2020.6789. JAMA Oncol. 2021. PMID: 33410866 Free PMC article.
-
A National Survey on Patient Provider Agreements When Prescribing Opioids for Chronic Pain.J Gen Intern Med. 2021 Mar;36(3):600-605. doi: 10.1007/s11606-020-06364-2. Epub 2021 Jan 8. J Gen Intern Med. 2021. PMID: 33420560 Free PMC article.
-
Perceptions of patient provider agreements.J Pharm Health Serv Res. 2015 Sep;6(3):139-144. doi: 10.1111/jphs.12099. Epub 2015 Jun 16. J Pharm Health Serv Res. 2015. PMID: 27293486 Free PMC article.
-
Clinical implications of patient-provider agreements in opioid prescribing.Curr Drug Saf. 2015;10(2):159-64. doi: 10.2174/1574886309666140922095844. Curr Drug Saf. 2015. PMID: 25986037 Review.
-
Beneficial opioid management strategies: A review of the evidence for the use of opioid treatment agreements.Subst Abus. 2020;41(2):208-215. doi: 10.1080/08897077.2019.1692122. Epub 2020 Jan 3. Subst Abus. 2020. PMID: 31900073 Review.
References
-
- de Vries F., Bruin M., Lobatto D.J., Dekkers O.M., Schoones J.W., van Furth W.R., Pereira A.M., Karavitaki N., Biermasz N.R., Najafabadi A.H.Z. Opioids and Their Endocrine Effects: A Systematic Review and Meta-analysis. J. Clin. Endocrinol. Metab. 2020;105:1020–1029. doi: 10.1210/clinem/dgz022. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources